title: [Immune complexes in diabetes mellitus].
abstract: Research in recent years has documented more exactly the genetic and immunopathogenetic basis of insulin-dependent diabetes mellitus. Also, in some genetically susceptible subjects, a triggering event activates both cellular and humoral immunity, with diminishing of b cellular mass. Early intervention to prevent diabetes development as well as to prevent microvascular complications is identification of individuals in whom autoimmunity has been activated. One of the non-specific tests is a screening test for the detection of circulating immune complexes /CIC/ by precipitating tests using polyethylene glycol it was performed in series of healthy, insulin-dependent and non-insulin dependent diabetic subjects. Highly increased precitability was seen in a great percentage of pathological sera. In spite of the non-specific method for immune complexes detection, positive results obtained by PEG method generally presumed that diabetes represent immune complex disease.
authors.forename: R
authors.initials: R
authors.lastname: Kocić
authors.forename: S
authors.initials: S
authors.lastname: Radenković
authors.forename: M
authors.initials: M
authors.lastname: Milenović
authors.forename: M
authors.initials: M
authors.lastname: Mijailović
authors.forename: G
authors.initials: G
authors.lastname: Koraćević
authors.forename: S
authors.initials: S
authors.lastname: Zivić
authors.forename: M
authors.initials: M
authors.lastname: Pesić
authors.forename: G
authors.initials: G
authors.lastname: Kosić
mesh_terms: D000936:Antigen-Antibody Complex / Q000097:blood*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D000936:Antigen-Antibody Complex